Cargando…
Closing gaps in medication taking for secondary prevention of coronary heart disease patients among US adults
BACKGROUND: The secondary preventive medical remedies used in the U.S. general population, particularly those with numerous co-morbidities, are poorly understood. We aimed to assess health outcomes and the extent of their adherence to guideline-based secondary prevention medications among U.S. coron...
Autores principales: | Liu, Xiaowei, Tang, Lijiang, Tang, Ying, Du, Changqing, Chen, Xiaofeng, Xu, Cheng, Yan, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667245/ https://www.ncbi.nlm.nih.gov/pubmed/36406714 http://dx.doi.org/10.1016/j.heliyon.2022.e11530 |
Ejemplares similares
-
Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Thakkar, Aarti, et al.
Publicado: (2021) -
Risk factor control among heart failure patients in the United States: Results from the NHANES 1999–2018
por: Tang, Ying, et al.
Publicado: (2022) -
Revisiting secondary prevention in coronary heart disease
por: Sigamani, Alben, et al.
Publicado: (2022) -
Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Tianyu, et al.
Publicado: (2021) -
Closing the gap for drowning prevention across Europe
por: Peden, Amy E, et al.
Publicado: (2022)